A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists
Open Access
- 15 December 2023
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 208 (12) , 1345-1346
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (No.82170043)
- State Key Laboratory of Respiratory Disease (SKLRD-OP-202305)
- National Natural Science Foundation of China (No.82170043)
- State Key Laboratory of Respiratory Disease (SKLRD-OP-202305)
This publication has 7 references indexed in Scilit:
- Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 DiabetesAmerican Journal of Respiratory and Critical Care Medicine, 2023
- Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patientsInternational Journal of Chronic Obstructive Pulmonary Disease, 2018
- Reduced Risk of Acute Exacerbation of COPD After Bariatric SurgeryChest, 2018
- Targeting Mechanisms Linking COPD to Type 2 Diabetes MellitusTrends in Pharmacological Sciences, 2017
- Obesity Is Associated With Increased Morbidity in Moderate to Severe COPDChest, 2017
- Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: The Overlap SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2010
- United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet TherapyAnnals of Internal Medicine, 1998